Home > Ana Carneiro, ESMO 2020 – Disparities in Access to Oncology Clinical Trials in Europe
Policy

Ana Carneiro, ESMO 2020 – Disparities in Access to Oncology Clinical Trials in Europe

Published Online: October 7th 2020
Authors: Ana Carneiro

At the Virtual 2020 ESMO Congress, Ana Carneiro talks about disparities in access to oncology trials from the last decade. The late-breaking abstract ‘Disparities in access to oncology clinical trials in Europe in the period 2009-2019‘ (LBA66) was presented at the Virtual 2020 ESMO Congress, 19–21 September 2020.

Questions

  1. Prior to this study, what was already known about disparities in cancer care and clinical trials across Europe? (0:14)
  2. Could you tell us a little about the aims and design of this study on access to oncology trials? (0:46)
  3. What were the findings of this study? (1:20)
  4. What are the limitations impacting access in clinical trials across European countries? (1:58)
  5. What can be done to address these inequalities? (2:48)

Speaker Disclosure: Ana Carneiro has nothing to disclose in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of the Virtual 2020 ESMO Congress.

Share this Video
Related Videos In Policy
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar